These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7314057)

  • 1. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays.
    Kitchen S; Preston FE
    Thromb Haemost; 1996 May; 75(5):734-9. PubMed ID: 8725715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.
    Toulon P; Boutière B; Horellou MH; Trzeciak MC; Samama MM
    Thromb Haemost; 1998 Jul; 80(1):104-8. PubMed ID: 9684794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between plasma concentration of heparin and biological response determined by 2 APTT reagents of different sensitivities].
    Bassini E; Miceli M; Cini S; Francalanci R
    Quad Sclavo Diagn; 1986 Jun; 22(2):193-200. PubMed ID: 3823368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid class composition and heparin sensitivity in the activated partial thromboplastin time.
    Stevenson KJ; Easton AC; Thomson JM; Poller L
    Thromb Haemost; 1983 Aug; 50(2):601-3. PubMed ID: 6636037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
    Okuda M; Yamamoto Y
    Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in heparin sensitivity of APTT reagents.
    Bjornsson TD; Nash PV
    Am J Clin Pathol; 1986 Aug; 86(2):199-204. PubMed ID: 3739971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
    Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
    Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer.
    Shojania AM; Tetreault J; Turnbull G
    Am J Clin Pathol; 1988 Jan; 89(1):19-23. PubMed ID: 3337049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythrophosphatide: a reagent for coagulation studies].
    Rakitianskaia AA; Khomich EN; Gilevskiĭ EN
    Lab Delo; 1982; (1):32-4. PubMed ID: 6174785
    [No Abstract]   [Full Text] [Related]  

  • 12. Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage.
    Kitchen S; Jennings I; Woods TA; Preston FE
    J Clin Pathol; 1996 Jan; 49(1):10-4. PubMed ID: 8666677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL; Howard C
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated partial thromboplastin time reagents: an evaluation.
    Howarth S
    Br J Biomed Sci; 1993 Jun; 50(2):109-13. PubMed ID: 8219915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The APTT monitoring of heparin--the ISTH/ICSH collaborative study.
    Van der Velde EA; Poller L
    Thromb Haemost; 1995 Jan; 73(1):73-81. PubMed ID: 7740500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The control of heparin therapy by the activated partial thromboplastin time: results of collaborative studies.
    Thomson JM
    Scand J Haematol Suppl; 1980; 37():73-83. PubMed ID: 6941440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time.
    Brandt JT; Triplett DA
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):530-7. PubMed ID: 7282639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of cumulative summation of differences method for determining APTT reagent suitability.
    Findlater SH
    Clin Lab Sci; 2012; 25(3):142-8. PubMed ID: 22953513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.